tiprankstipranks
Trending News
More News >
CytomX Therapeutics Inc. (CTMX)
NASDAQ:CTMX

Compare CytomX Therapeutics (CTMX) vs. Competitors

Compare
891 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CytomX Therapeutics
$5.72
$909.87M
13.68
583.39%
6 Buy
1 Hold
0 Sell
Strong Buy
Lexicon Pharmaceuticals
$1.76
$476.05M
-9.29
109.52%
3 Buy
0 Hold
0 Sell
Strong Buy
Verastem
$6.69
$500.88M
-1.57
21.20%
5 Buy
0 Hold
0 Sell
Strong Buy
Arcturus Therapeutics
$7.59
$201.74M
-3.08
-54.66%
6 Buy
3 Hold
0 Sell
Moderate Buy
KalVista Pharmaceuticals
$16.54
$773.86M
-4.14
93.22%
8 Buy
0 Hold
0 Sell
Strong Buy
Bicycle Therapeutics
$7.22
$462.27M
-1.99
-45.30%
6 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTMX
CytomX Therapeutics
5.72
4.83
542.70%
LXRX
Lexicon Pharmaceuticals
1.76
0.77
77.78%
VSTM
Verastem
6.69
0.77
13.01%
ARCT
Arcturus Therapeutics
7.59
-9.53
-55.67%
KALV
KalVista Pharmaceuticals
16.54
7.93
92.10%
BCYC
Bicycle Therapeutics
7.22
-5.76
-44.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts